000			01525 a2200457 4500
005			20250516065806.0
264		0	_c20120327
008			201203s 0 0 eng d
022			_a1532-1770
024	7		_a10.1016/j.berh.2011.10.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aVerstappen, Suzanne M M
245	0	0	_aWhat is the outcome of RA in 2011 and can we predict it? _h[electronic resource]
260			_bBest practice & research. Clinical rheumatology _cAug 2011
300			_a485-96 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAge of Onset
650	0	4	_aAntirheumatic Agents _xtherapeutic use
650	0	4	_aArthritis, Rheumatoid _xdiagnosis
650	0	4	_aArthrography
650	0	4	_aAutoimmunity _xphysiology
650	0	4	_aCardiovascular Diseases _xepidemiology
650	0	4	_aComorbidity
650	0	4	_aDisease Progression
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aJoints _xpathology
650	0	4	_aLung Diseases _xepidemiology
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aRisk Factors
650	0	4	_aSex Factors
650	0	4	_aSmoking _xadverse effects
650	0	4	_aSurvival Rate
650	0	4	_aTreatment Outcome
700	1		_aSymmons, Deborah P M
773	0		_tBest practice & research. Clinical rheumatology _gvol. 25 _gno. 4 _gp. 485-96
856	4	0	_uhttps://doi.org/10.1016/j.berh.2011.10.008 _zAvailable from publisher's website
999			_c21363109 _d21363109